Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
More
BMY - Bristol-Myers Squibb Co Stock Price, Fair Value and News
44.04
USD
-0.07
(-0.16%)
Market Closed
Watchlist
Share
Stock
/
BMY
/
Insider-Transactions
Latest Insider Trading transactions for BMY
CSV
Date
sorted ascending
Name
Buy/Sell
$ Value
# Shares
Avg. Price
Title
2024-04-01
Premium
acquired
Premium
Premium
Premium
EVP, Glob. Prod. Dev. & Supply
2024-04-01
Premium
sold (taxes)
Premium
Premium
Premium
EVP, Glob. Prod. Dev. & Supply
2024-03-10
Premium
acquired
Premium
Premium
Premium
President, Cell Therapy Org.
2024-03-10
Premium
acquired
Premium
Premium
Premium
EVP, Chief Financial Officer
2024-03-10
Premium
sold
Premium
Premium
Premium
EVP,Chief Med.Offr.,Drug Dev.
2024-03-10
Premium
sold
Premium
Premium
Premium
Executive Chair of the Board
2024-03-10
Premium
sold (taxes)
Premium
Premium
Premium
President, Cell Therapy Org.
2024-03-10
Premium
sold (taxes)
Premium
Premium
Premium
EVP, Chief Research Officer
2024-03-10
Premium
sold (taxes)
Premium
Premium
Premium
EVP, Corporate Affairs
2024-03-10
Premium
sold (taxes)
Premium
Premium
Premium
EVP, General Counsel
2024-03-10
Premium
sold
Premium
Premium
Premium
EVP, General Counsel
2024-03-10
Premium
sold
Premium
Premium
Premium
SVP and Controller
2024-03-10
Premium
sold
Premium
Premium
Premium
EVP, Chief Financial Officer
2024-03-10
Premium
acquired
Premium
Premium
Premium
EVP, Chief Research Officer
2024-03-10
Premium
sold (taxes)
Premium
Premium
Premium
EVP, Chief Human Resources
2024-03-10
Premium
sold
Premium
Premium
Premium
EVP, Corporate Affairs
2024-03-10
Premium
acquired
Premium
Premium
Premium
Executive Chair of the Board
2024-03-10
Premium
sold (taxes)
Premium
Premium
Premium
EVP, Chief Financial Officer
2024-03-10
Premium
acquired
Premium
Premium
Premium
EVP,Chief Med.Offr.,Drug Dev.
2024-03-10
Premium
sold (taxes)
Premium
Premium
Premium
Chief Executive Officer
2024-03-10
Premium
sold
Premium
Premium
Premium
President, Cell Therapy Org.
2024-03-10
Premium
sold
Premium
Premium
Premium
EVP, Chief Human Resources
2024-03-10
Premium
sold
Premium
Premium
Premium
EVP, Chief Research Officer
2024-03-10
Premium
acquired
Premium
Premium
Premium
EVP, Corporate Affairs
2024-03-10
Premium
sold (taxes)
Premium
Premium
Premium
EVP,Chief Med.Offr.,Drug Dev.
Rows per page:
10
25
50
All
1–25 of 50